Brief: Cytek Biosciences Q1 Revenue USD 44.135 Million
07/05/2026 21:05
May 07 (Reuters) - Cytek Biosciences Q1 adjusted gross margin 48%. Q1 pretax profit USD -17.373 million Q1 net income USD -18.866 million Q1 adjusted EBITDA USD -9.073 million outlook FY revenue USD 205-212 million vs. IBES estimate USD 208.2 million
Recent news on Cytek Biosciences
See all newsCytek owes Beckman Coulter $56 mln in cell-analysis patent case, US jury says (updated)
Cytek owes Beckman Coulter $56 mln in cell-analysis patent case, US jury says
Cytek Biosciences, Inc. reports results for the quarter ended June 30 - Earnings Summary
Cytek Biosciences Q2 revenue slightly misses estimates
Brief: Cytek Biosciences Q2 Revenue USD 48.14 Million